The {pharmaceutical market is rapidly exploring novel treatment strategies for obesity , and the emergence of semaglutide 10mg doses represents the development . Healthcare providers are cautiously assess here the likely benefits and risks associated with this higher potency product, particularly in comparison to existing lower-dose semaglutide pro